Company profile
Kyverna Therapeutics
Harnessing the power of cell therapy in autoimmune disease.
- Industry
- Biotechnology Research
- Employees
- 162
- Headquarters
- Emeryville, California
- Founded
- 2018
- LinkedIn followers
- 43,255
- Office locations
- 1
Kyverna Therapeutics company summary
Kyverna Therapeutics is a company in the Biotechnology Research industry, headquartered in Emeryville, California, founded in 2018. On LinkedIn the company has around 162 employees and 43,255 followers. Its listed specialties include cell therapy, autoimmune, lupus, multiple sclerosis, systemic sclerosis.
What technology does Kyverna Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Kyverna Therapeutics
Kyverna is a clinical-stage biopharmaceutical company focused on liberating autoimmune patients through the curative potential of cell therapy. Kyverna’s lead autologous CD19-targeting CAR T-cell therapy candidate, miv-cel (mivocabtagene autoleucel, KYV-101), has demonstrated the potential to fundamentally change the treatment paradigm across multiple B-cell-driven autoimmune diseases. Kyverna is advancing its potentially first-in-class neuroimmunology franchise with its recently completed registrational trial in stiff person syndrome and an ongoing registrational trial for generalized myasthenia gravis. The Company is also harnessing other KYSA trials and investigator-initiated trials, including in multiple sclerosis and rheumatoid arthritis, to inform the next priority indications. Additionally, its next generation pipeline includes CAR T-cell therapies deploying novel innovations to improve patient access and experience.
Specialties
Where is Kyverna Therapeutics located?
Kyverna Therapeutics lists 1 location.
Compare companies similar to Kyverna Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Kyverna Therapeutics kyvernatx.com | Biotechnology Research | 162 | 2018 | Emeryville, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Kyverna Therapeutics
What does Kyverna Therapeutics do?
Kyverna is a clinical-stage biopharmaceutical company focused on liberating autoimmune patients through the curative potential of cell therapy. Kyverna’s lead autologous CD19-targeting CAR T-cell therapy candidate, miv-cel (mivocabtagene autoleucel, KYV-101), has demonstrated the potential to fundamentally change the treatment paradigm across multiple B-cell-driven autoimmune diseases. Kyverna is advancing its potentially first-in-class neuroimmunology franchise with its recently completed registrational trial in stiff person syndrome and an ongoing registrational trial for generalized myasthenia gravis. The Company is also harnessing other KYSA trials and investigator-initiated trials, including in multiple sclerosis and rheumatoid arthritis, to inform the next priority indications. Additionally, its next generation pipeline includes CAR T-cell therapies deploying novel innovations to improve patient access and experience.
How many employees does Kyverna Therapeutics have?
Kyverna Therapeutics has around 162 employees on LinkedIn.
Where is Kyverna Therapeutics headquartered?
Kyverna Therapeutics is headquartered in Emeryville, California.
When was Kyverna Therapeutics founded?
Kyverna Therapeutics was founded in 2018.
Build a lead list from companies like Kyverna Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.